JP2022513459A5 - - Google Patents

Info

Publication number
JP2022513459A5
JP2022513459A5 JP2021533527A JP2021533527A JP2022513459A5 JP 2022513459 A5 JP2022513459 A5 JP 2022513459A5 JP 2021533527 A JP2021533527 A JP 2021533527A JP 2021533527 A JP2021533527 A JP 2021533527A JP 2022513459 A5 JP2022513459 A5 JP 2022513459A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
orf1
acid sequence
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021533527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513459A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/065963 external-priority patent/WO2020123795A2/en
Publication of JP2022513459A publication Critical patent/JP2022513459A/ja
Publication of JP2022513459A5 publication Critical patent/JP2022513459A5/ja
Priority to JP2024075364A priority Critical patent/JP2024099833A/ja
Withdrawn legal-status Critical Current

Links

JP2021533527A 2018-12-12 2019-12-12 タンパク質代替治療モダリティを送達するためのアネロソーム Withdrawn JP2022513459A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075364A JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862778861P 2018-12-12 2018-12-12
US201862778866P 2018-12-12 2018-12-12
US62/778,866 2018-12-12
US62/778,861 2018-12-12
PCT/US2019/065963 WO2020123795A2 (en) 2018-12-12 2019-12-12 Anellosomes for delivering protein replacement therapeutic modalities

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075364A Division JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Publications (2)

Publication Number Publication Date
JP2022513459A JP2022513459A (ja) 2022-02-08
JP2022513459A5 true JP2022513459A5 (cg-RX-API-DMAC7.html) 2022-12-20

Family

ID=69160356

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533527A Withdrawn JP2022513459A (ja) 2018-12-12 2019-12-12 タンパク質代替治療モダリティを送達するためのアネロソーム
JP2024075364A Pending JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075364A Pending JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Country Status (11)

Country Link
US (1) US20220073950A1 (cg-RX-API-DMAC7.html)
EP (1) EP3894569A2 (cg-RX-API-DMAC7.html)
JP (2) JP2022513459A (cg-RX-API-DMAC7.html)
KR (1) KR20210125990A (cg-RX-API-DMAC7.html)
CN (1) CN114127303A (cg-RX-API-DMAC7.html)
AU (1) AU2019395418A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021010925A2 (cg-RX-API-DMAC7.html)
CA (1) CA3119814A1 (cg-RX-API-DMAC7.html)
IL (1) IL283781A (cg-RX-API-DMAC7.html)
MX (1) MX2021006945A (cg-RX-API-DMAC7.html)
WO (1) WO2020123795A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11624061B2 (en) 2017-04-28 2023-04-11 Agrospheres, Inc. Compositions and methods for enzyme immobilization
BR112019022539A2 (pt) 2017-04-28 2020-06-16 Agrospheres, Inc. Composições e métodos para o encapsulamento e entrega escalonável de agorquímicos
BR112020005803A2 (pt) 2017-09-25 2020-12-01 Agrospheres, Inc. composições e métodos para produção e administração moduláveis de produtos biológicos
CA3121528A1 (en) 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
AU2021288320A1 (en) * 2020-06-12 2023-01-19 Flagship Pioneering Innovations V, Inc. Tandem anellovirus constructs
KR20230041686A (ko) * 2020-06-17 2023-03-24 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 아넬로바이러스를 확인 및 특징화하는 방법 및 이의 용도
CA3206361A1 (en) * 2020-12-23 2022-06-30 Flagship Pioneering Innovations V, Inc. In vitro assembly of anellovirus capsids enclosing rna
MX2024004492A (es) * 2021-10-12 2024-05-31 Flagship Pioneering Innovations V Inc Composiciones y metodos de anellovector novedosos.
WO2023069948A1 (en) * 2021-10-18 2023-04-27 Flagship Pioneering Innovations Vii, Llc Dna compositions and related methods
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
US9676828B2 (en) * 2010-06-23 2017-06-13 Deutsches Krebsforschungszentrum Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
CA3066750A1 (en) * 2017-06-13 2018-12-20 Flagship Pioneering Innovations V, Inc. Compositions comprising curons and uses thereof
CA3121528A1 (en) * 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
US20230048858A1 (en) * 2018-12-12 2023-02-16 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering secreted therapeutic modalities
EP3894567A2 (en) * 2018-12-12 2021-10-20 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering intracellular therapeutic modalities

Similar Documents

Publication Publication Date Title
JP2022512395A5 (cg-RX-API-DMAC7.html)
JP2022513797A5 (cg-RX-API-DMAC7.html)
JP2022514501A5 (cg-RX-API-DMAC7.html)
KR101817482B1 (ko) 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정
CN114736901B (zh) 用于减少pd-l1表达的寡核苷酸
US20260009050A1 (en) Anellosomes for delivering secreted therapeutic modalities
CN118256490A (zh) 一种环状rna、组合物和治疗疾病的方法
JP2019508364A (ja) 免疫抑制療法中のjcウイルス活性化およびpml(進行性多巣性白質脳症)のリスクを除去するための遺伝子編集方法および組成物
JP2024533312A5 (cg-RX-API-DMAC7.html)
ES2552793T3 (es) Variantes de SAP y su uso
CN110393791B (zh) hnRNPA2B1的抗感染作用及其应用
KR20210131310A (ko) 아넬로좀 및 사용 방법
CA3119814A1 (en) Anellosomes for delivering protein replacement therapeutic modalities
US20250011766A1 (en) Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
CA3119339A1 (en) Anellosomes for delivering intracellular therapeutic modalities
TW202223095A (zh) 串聯指環病毒構築體
KR20250053925A (ko) CRISPR-Cas13 시스템 및 이의 용도
KR20230124682A (ko) Rna를 봉입하는 아넬로바이러스 캡시드의 시험관 내어셈블리
Su et al. Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization
WO2018168586A1 (ja) ボルナウイルスベクター及びその利用
JP2024543994A (ja) 硝子体内投与用の機能性aavカプシド
CA2251818A1 (en) Mammalian genes involved in viral infection and tumor suppression
US20260071211A1 (en) Genome Editing Compositions and Methods for Treatment of Friedreich's Ataxia
WO2025045079A1 (zh) 一种基于rna特异性脱氨酶突变体及其应用
KR20260007637A (ko) 원형 rna 및 이의 제조방법